T32 Training Grant in“Integrative Cardiovascular Pathophysiology”
Director: Steven R. Houser, PhD Co-Director: Walter J. Koch, PhD
This recently renewed T32 Training Grant supported by the National Heart, Lung and Blood Institute (NHLBI) of the NIH is recruiting eligible Post-Doctoral Fellows. This Program led at Temple University’s Lewis Katz School of Medicine (LKSOM) in Philadelphia supports training in “Integrative Cardiovascular Pathophysiology” (ICVP). This interdisciplinary training program involves the Cardiovascular Research Center (CVRC), directed by Dr. Steven Houser, but also involves Cardiovascular Researchers within other units at LKSOM. Many researchers are housed in our Center for Translational Medicine (CTM), directed by Dr. Walter J. Koch (ICVP Co-Director). The ICVP training program also includes faculty from our Sol Sherry Thrombosis Research Center (SSTRC; Directed by Dr. Satya Kunapuli) and a new branch of cardiovascular research within the Center for Metabolic Disease Research (CMDR: Directed by Dr. Hong Wang). Collaborative NIH-funded cardiovascular research is going on within and between all of these research centers. There are also collaborative research projects with other Temple Colleges, including the College of Engineering (bioengineering).
Trainees will have the opportunity to conduct cutting-edge cardiovascular research with the goals to help them succeed as biomedical science professionals. In their research work, trainees will explore fundamental cellular, molecular and physiological mechanisms of major cardiovascular diseases and learn how to translate this new knowledge into a better understanding of cardiovascular diseases. Our studies also explore novel approaches to prevent or reverse these disorders. The studies performed by ICVP faculty are defining the basis of those cardiovascular diseases that cause significant morbidity and premature mortality in the US and world. A significant component of our research is to translate our findings into novel therapies that prevent or reverse debilitating cardiovascular diseases such as heart failure. Fellows in this program learn modern approaches to manipulate genes and signaling pathways thought to be involved in disease induction and/or progression within cells and tissues of the cardiovascular system and to define their roles in disease induction, progression, prevention and recovery. There is an emphasis on training that helps Fellows learn how to develop projects that have the potential to have impact on the treatments for patients with cardiovascular diseases.
Program Eligibility: NIH T32 requires that trainees must be United States citizen on a non-citizen national, or have been lawfully admitted for permanent residence by training appointment date.
Post-Doctoral Appointments: Candidates for Post-Doctoral (MD and/or PhD degree required) support on this T32 will be reviewed by the Appointments and Executive Committee and currently, has open recruitment. Initial appointments will be fore 2 years in the desired or agreed upon laboratory. If interested, please send your letter of interest and CV to Dr. Houser (firstname.lastname@example.org) or Dr. Koch (email@example.com).
Internal Number: T322020
About Temple University, Lewis Katz School of Medicine
Laboratory focusing on molecular aspects of Heart Failure and experimental therapeutics. Signal transduction mechanisms and metabolism are being pursued.